These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22130318)

  • 1. Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
    Yufu K; Takahashi N; Okada N; Shinohara T; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
    Circ J; 2012; 76(2):399-404. PubMed ID: 22130318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined assessment of baroreflex sensitivity with iodine 123 metaiodobenzylguanidine scintigraphic findings strengthens the power of predictive value for cerebral and cardiovascular events in type 2 diabetic patients.
    Murozono Y; Yufu K; Takahashi N; Okada N; Shinohara T; Nakagawa M; Hara M; Saikawa T
    Circ J; 2013; 77(1):130-6. PubMed ID: 23018680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iodine-123 metaiodobenzylguanidine imaging can predict future cardiac events in Japanese patients with Parkinson's disease.
    Kinbara T; Hayano T; Otani N; Furutani Y; Tanaka S
    Ann Nucl Med; 2013 Feb; 27(2):123-31. PubMed ID: 23086545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus.
    Tamura K; Utsunomiya K; Nakatani Y; Saika Y; Onishi S; Iwasaka T
    Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
    Nagamatsu H; Momose M; Kobayashi H; Kusakabe K; Kasanuki H
    Ann Nucl Med; 2007 Nov; 21(9):513-20. PubMed ID: 18030583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Heart; 2011 Jan; 97(1):20-6. PubMed ID: 21062772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial cardiac 123I-metaiodobenzylguanidine scintigraphic studies are more useful for predicting cardiac death than one-time scan in patients with chronic heart failure: sub-analysis of our previous report.
    Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
    Nucl Med Commun; 2010 Sep; 31(9):807-13. PubMed ID: 20543756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
    Yamada T; Shimonagata T; Fukunami M; Kumagai K; Ogita H; Hirata A; Asai M; Makino N; Kioka H; Kusuoka H; Hori M; Hoki N
    J Am Coll Cardiol; 2003 Jan; 41(2):231-8. PubMed ID: 12535815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of
    Hashimoto H; Nakanishi R; Mizumura S; Hashimoto Y; Okamura Y; Yamanaka K; Yamazaki J; Ikeda T
    J Nucl Cardiol; 2020 Jun; 27(3):833-842. PubMed ID: 30386980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
    Narita M; Kurihara T
    J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
    Kuramoto Y; Yamada T; Tamaki S; Okuyama Y; Morita T; Furukawa Y; Tanaka K; Iwasaki Y; Yasui T; Ueda H; Okada T; Kawasaki M; Levy WC; Komuro I; Fukunami M
    Am J Cardiol; 2011 Apr; 107(8):1185-90. PubMed ID: 21349482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late gadolinium enhancement on cardiac magnetic resonance combined with 123I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy.
    Chimura M; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
    PLoS One; 2019; 14(6):e0217865. PubMed ID: 31220100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.
    Kioka H; Yamada T; Mine T; Morita T; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Hori M; Fukunami M
    Heart; 2007 Oct; 93(10):1213-8. PubMed ID: 17344327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
    Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
    J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal iodine
    Okabe Y; Murai H; Tokuhisa H; Hamaoka T; Mukai Y; Sugimoto H; Takashima SI; Kato T; Matsuo S; Usui S; Furusho H; Takamura M; Kaneko S
    Auton Neurosci; 2020 Jul; 226():102671. PubMed ID: 32272358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early effects of transcatheter aortic valve replacement on cardiac sympathetic nervous function assessed by
    Kadoya Y; Zen K; Tamaki N; Ito N; Kuwabara K; Yamano M; Yamano T; Nakamura T; Matsushima S; Oka K; Numata S; Yaku H; Matoba S
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(7):1657-1667. PubMed ID: 31502014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.